STipe Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- STipe Therapeutics's estimated annual revenue is currently $6.4M per year.
- STipe Therapeutics's estimated revenue per employee is $155,000
Employee Data
- STipe Therapeutics has 41 Employees.
- STipe Therapeutics grew their employee count by 5% last year.
STipe Therapeutics's People
| Name | Title | Email/Phone |
|---|
STipe Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is STipe Therapeutics?
STipe Therapeutics is a privately held biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The Company was spun out from Aarhus University, Denmark in 2018 and concluded a EUR 20 million a Series A financing in September 2019.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Denmark
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.7M | 46 | 15% | N/A |
#2 | $8.6M | 53 | 18% | N/A |
#3 | $13.8M | 61 | -3% | N/A |
#4 | $14.2M | 79 | 41% | N/A |
#5 | $24.9M | 86 | 8% | N/A |